Member Info for johnlaycock

Neither! We are beholden to both NHSE and NICE so these things never happen quickly!

We knew Cardiff was part of the PALOH roll out but here is a link confirming North Wales too.

https://www.linkedin.com/posts/oliverrackham_paloh-bcuhb-genedrive-activity-7349709533688070144-QR84?utm_source=share&utm_medium=member_android&rcm=ACoAAAAMhbsB_NgSe9dupPlFVCvI337zRJ75xs8

To be fair, the company is not able to dictate when the pilot study findings and implementation guide is published as its with the regulatory authorities who operate at their own pace. Let's hope it is delivered soon and we can all move on from this depressing SP.

It's a new website as they have just updated the original message.

Https://www.linkedin.com/posts/genedrive-plc_gdr-activity-7348008603653402624-yMC4?utm_source=share&utm_medium=member_android&rcm=ACoAAAAMhbsB_NgSe9dupPlFVCvI337zRJ75xs8

I'm still convinced that once a big RNS lands on a signficant milestone ( national commissioning etc), a predator will move on quickly. The NHS 10yr plan published this week makes it very clear, genomics is the future.

Https://www.linkedin.com/posts/ryan-cooper-2a453945_point-of-care-testing-coordinatoredinburgh-activity-7346477430519349252-HC59?utm_source=share&utm_medium=member_android&rcm=ACoAAAAMhbsB_NgSe9dupPlFVCvI337zRJ75xs8

More positive news

https://www.gov.uk/government/news/innovator-passports-set-to-accelerate-cutting-edge-nhs-care

Https://www.nice.org.uk/news/articles/nice-welcomes-the-inclusion-of-measures-for-equal-treatment-of-medicines-and-health-technologies

Roger. You might have missed the important bit here in that its NHSE/NICE who will determine when the implementation guidance is published and not the company. To suggest therefore that the Directors have some influence on the publication date is for the birds.

Https://www.ii-sa.com/genomics-precision-medicine-solutions

Roger - how do you know PH still hold all their shares? No-one holds over 3% of the shares.

Great find Lionel. The future is even brighter!

Roger - they are months away from cost/revenue break even so the question is how do they get there. No chance given the direction of travel for the appetite (both UK and International) of their tests, the NHS investment to date and the regulatory approvals , they wont make it - I think they have enough cash until October and that's without factoring in revenue from March until now and forward revenue from now until October. We know what this revenue is but what we don't know is the unknown revenue (i.e from international and UK hospitals that have ordered the tests). We also know the NICE guidance is due any day for the implementation of CYP2C19 national testing and PCT's will play a major role in this. As Jimi pointed out the forecasts for annual CYP2C19 testing in the UK has just been upgraded to 18m so even a modest % of this market will completely transform the fortunes of the company. That's why I wouldn't be surprised if a predator got in early to take out the company given the potential and imminent income from both the UK and Internationally. Exciting times ahead. I wouldn't be surprised if we heard about the implementation plans from NICE this week (I note they have updated their website to confirm the pilot is over and the findings are being considered).

They have cash until October and that doesn't include any sales revenue in the last few months or indeed. It also doesn't include sales from the imminent CYP2C19 roll out so who knows they might need not need to raise any pre breaking even???

Thanks Eureka - just one clarification . The CYP2C19 NHSE pilot finished end May so the conclusion Gino referred to as due now is how they intend to implement a national roll out as recommended by NICE. This will be a mixture of PCT and Lab tests and one can reasonably assume immediate revenue will come from this. I suspect given Gino's comment we could hear as early as next week via an update on this:

https://www.nice.org.uk/guidance/DG59

This will be transformational news for the company! NHSE will not want Scotland to roll this out before they start.

We knew about the site installation in Saudi Arabia from the half yr report but he also mentioned that on the back of this, he was expecting other SA hospitals to adopt soon.

Also very interesting that some UK hospitals are using the MT-RNR1 test not just in NICU's but in neonatal units too.

V interesting that Gino confirmed in the presentation that the implementation plan for CYP2C19 roll out is due 'around about now'.

Thanks Lionel - the post is very interesting as it suggest Labs are buying the GDR tests?

Roger...if it's done and you aren't a shareholder why are spending so long on this board posting ?